Is it Advantageous to Use Quality by Design (Qbd) to Develop Nanoparticle-Based Dosage Forms for Parenteral Drug Administration?
AuthID
P-010-D4E
P-010-D4E
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service